⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 31, 2026Brain

A tight match: comparing the effectiveness of immune reconstitution therapies for multiple sclerosis

Paolo A. Muraro Eleonora De Matteis Antonio Scalfari

View at Publisher

Ask AI

Bookmark

Share

Key Points

This commentary evaluates the effectiveness of various immune reconstitution therapies for treating multiple sclerosis.
Analysis of existing research comparing treatment outcomes of different therapies.
Focus on haematopoietic stem cell transplant versus other immune therapies.
Examination of metrics related to effectiveness and patient outcomes.
Identified considerable differences in therapy effectiveness for multiple sclerosis.
Highlighted specific scenarios where each therapy may be more beneficial.
Indicated the need for tailored treatment approaches based on individual patient needs.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Commentary compares immune reconstitution therapies in relapsing multiple sclerosis, highlighting implications for treatment choices.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Muraro et al. (2026) studied this question.

synapsesocial.com/papers/698435fff1d9ada3c1fb5808 https://doi.org/10.1093/brain/awag044

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis2025 · 6 citations
2Comparison of anti-human T cell globulins on immune reconstitution and early infections after autologous transplant in patients with multiple sclerosis2025
3Comparison of anti-human T cell globulins on immune reconstitution and early infections after autologous transplant in patients with multiple sclerosis2025 · 1 citations
4Immune Reconstitution After Hematopoietic Stem Cell Transplantation: Cellular Dynamics, Clinical Determinants, and Emerging Therapeutic StrategiesNarrative Review · 2026
5Immune reconstitution and tolerance-inducing therapies as promising therapeutic approaches in multiple sclerosisReview · 2026

More related papers

Bruton’s Tyrosine Kinase Inhibitors and Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: A Review of Complementary Paradigms for a Divergent Disease2026
Autologous haematopoietic stem cell transplantation in multiple sclerosis: outcomes and predictors from German real-world data2026
Lymphocyte subset reconstitution and clinical outcomes following haploidentical hematopoietic stem cell transplantation2026

More from Brain

Preventing autoimmunity after alemtuzumab in multiple sclerosis: regulatory T cells resist expansionWed,
Prematurity insults remodel cerebellar development and behaviourWed,